Experon Pharmaceuticals Private Limited
About Experon Pharmaceuticals Private Limited
Data last updated:
Experon Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2017PTC092775.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Shobhna Khare and Aadarsh Vijay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 191 Maya Bazar North Gate, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.88 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹2,011 (net margin -1.1%) and EBITDA of ₹1.04 Lakh (EBITDA margin 55.1%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 35% over five years.
As per MCA filings, the company has open charges of ₹9 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Experon Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address191 Maya Bazar North Gate, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Experon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Experon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Experon Pharmaceuticals Private Limited, buy the company report.
Financials of Experon Pharmaceuticals Private Limited
FY 2025 filings availableExperon Pharmaceuticals Private Limited reported revenue of ₹1.88 Lakh (down 51% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 35% over five years, including a 51% fall in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,011 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 55.1% | ||||
| Net Profit Margin | -1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Experon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Experon Pharmaceuticals Private Limited
Experon Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shobhna Khare | Director | 01 May 2017 | 9 Years 5 Months | Current |
| Aadarsh Vijay | Director | 01 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Experon Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neophyte Pharmaceuticals Private Limited | ₹1.91 Lakh (FY 2024) | -72.0% | Patna, Bihar, India | |||
| Vindhyachal Pharmaceuticals Private Limited | ₹1.89 Lakh (FY 2019) | -94.0% | Umarkhed, Maharashtra, India | |||
| Megsan Pharmaceuticals Private Limited | ₹1.89 Lakh (FY 2025) | -35.0% | Cuttack, Odisha, India | |||
| Experon Pharmaceuticals Private Limitedthis company | ₹1.88 Lakh (FY 2025) | -₹2,011 | -1.1% | -51.0% | Gorakhpur, Uttar Pradesh, India | |
| Hindraj Pharmaceuticals Private Limited | ₹1.88 Lakh (FY 2023) | 795.0% | Delhi, India | |||
| Sofitt Pharmaceuticals Private Limited | ₹1.87 Lakh (FY 2020) | Pataudi, Haryana, India |
To see the full peer comparison of Experon Pharmaceuticals Private Limited, buy the company report.
Auditor
Experon Pharmaceuticals Private Limited is audited by T K & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T K & ASSOCIATES | FY 2021 | 028474C |
Shareholding
The shareholding of Experon Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Experon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Dec 2019 | 100324815 | Others | ₹9 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Experon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Experon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Experon Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Experon Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Aadarsh Vijay was appointed as Director on 01 May 2017.
Frequently asked questions
Experon Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 May 2017 (9+ years old) and is registered under CIN U51909UP2017PTC092775.
Experon Pharmaceuticals has 2 current directors:
- Shobhna Khare - Director
- Aadarsh Vijay - Director
The latest financial statements of Experon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Experon Pharmaceuticals is U51909UP2017PTC092775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Experon Pharmaceuticals was incorporated on 01 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Experon Pharmaceuticals by revenue are Neophyte Pharmaceuticals Private Limited, Vindhyachal Pharmaceuticals Private Limited, Megsan Pharmaceuticals Private Limited, Hindraj Pharmaceuticals Private Limited, Sofitt Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Aadarsh Vijay was appointed as Director on 01 May 2017. Shobhna Khare was appointed as Director on 01 May 2017.
The registered office of Experon Pharmaceuticals is at 191 Maya Bazar North Gate, Gorakhpur, Uttar Pradesh, India – 273001.
Experon Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Experon Pharmaceuticals has open charges of ₹9 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Experon Pharmaceuticals is active non-compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.